Samuel Bates Martin, SVP and CFO at Celldex Therapeutics, Inc. (CLDX), sold 19,000 shares at $42.27 ($828K) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Open-market sale of $828k CLDX by SVP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.27 | 2,048 | $87K | 10.5% |
| 2 | $42.27 | 2,048 | $87K | 10.5% |
| 3 | $43.92 | 7,452 | $327K | 39.5% |
| 4 | $43.92 | 7,452 | $327K | 39.5% |
| Total | $43.56 avg | 19,000 | $828K | 100% |
| Filing → |
| CLDX | SELL | 2022-08-15 | $1.4M | — | Filing → |
| CLDX | SELL | 2021-12-28 | $399K | — | Filing → |
| CLDX | SELL | 2021-08-12 | $124K | — | Filing → |